• Reducing the number of shots is important because streamlining the vaccination process should help increase the number of young people who get fully vaccinated against meningococcal disease. (medscape.com)
  • In some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit. (medlineplus.gov)
  • Meningococcal B vaccination should be postponed for pregnant people unless the person is at increased risk and, after consultation with their health care provider, the benefits of vaccination are considered to outweigh the potential risks. (medlineplus.gov)
  • The meningococcal B vaccine (MenB) protects against a fifth type of meningococcal bacterium (called type B). It is fairly new and not yet recommended as a routine vaccination for healthy people. (kidshealth.org)
  • Vaccination is used for close contacts of patients with meningococcal disease due to A, C, Y, or W135 serogroups, to prevent secondary cases. (medscape.com)
  • The conjugate vaccine (MCV4, protecting against serogroups A, C, W, and Y) is preferred for people 9 months to 55 years old and is used for routine childhood vaccination (see CDC: Meningococcal ACWY vaccine information statement ). (msdmanuals.com)
  • The vaccine currently in use is a Meningococcal Polysaccharides, Immunity after one vaccination lasts for three years. (gov.tw)
  • While vaccination against meningococcal disease is the most important prevention strategy, influenza vaccination could provide further protection, particularly in young children where the meningococcal disease vaccine is not recommended or protective against the most common serogroup. (nih.gov)
  • The booster dose recommendation was made in 2010 after studies noted that only 50 percent of adolescents vaccinated at age 11-12 had sufficient vaccine-acquired antibodies to protect them against meningococcal disease five years post-vaccination. (nvic.org)
  • The committee came to this conclusion after evaluating multiple factors including the high number of people that would require vaccination in order to prevent a single case of meningococcal disease, the low rates of the disease, the vaccine's cost, lack of efficacy and safety data as well as the potential risk that serious adverse reactions would exceed the number of cases potentially prevented from the vaccine. (nvic.org)
  • As of December 1, 2023 , there had been 135 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following meningococcal vaccination, including 3 deaths and 132 serious injuries. (nvic.org)
  • In advance, please check with your insurance carrier regarding coverage for receiving a meningococcal B vaccination at OSU. (oregonstate.edu)
  • Therefore, CDC recommends resuming routine vaccination for all recommended groups according to ACIP recommendations, including children aged 11--12 years and, if not previously vaccinated with MCV4, of adolescents at high-school entry (at approximately age 15 years), of college freshmen living in dormitories, and of other persons at increased risk for meningococcal disease. (cdc.gov)
  • Learn what the latest guidelines from the American Academy of Pediatrics recommend for meningococcal vaccination among children, adolescents, and young adults. (pharmacytimes.com)
  • A variety of routine childhood and adolescent meningococcal vaccination programs using monovalent (serogroup C) and quadrivalent (A, C, Y, W) conjugate vaccines have been implemented in Canada since 2002, resulting in a decrease in invasive meningococcal disease (IMD) incidence, particularly in serogroup C. Meningococcal vaccines have also been used for outbreak response, including the multicomponent vaccine serogroup B vaccine. (canada.ca)
  • Since the early 2000s, a variety of routine childhood and adolescent vaccination programs using monovalent (serogroup C) and quadravalent (serogroup A, C, Y and W-135) meningococcal conjugate vaccines have been implemented in Canada Footnote 3 . (canada.ca)
  • This has resulted in a decrease in IMD incidence, particularly for serogroup C. In the last decade, the multicomponent meningococcal B vaccine (4CMenB) has been used to control outbreaks Footnote 3 but has not been used in routine vaccination programs across the country. (canada.ca)
  • According to the Meningococcal Vaccines Market report, the increase in awareness about vaccination and immunization programs will lead to the growth of this market. (sbwire.com)
  • These data represent administrative and official Meningococcal vaccination coverage reported annually through the WHO/UNICEF Joint Reporting Form on Immunization (JRF). (who.int)
  • Approval was based on three randomized studies in about 2800 adolescents, in which 82% of subjects given three doses of the vaccine developed antibodies against four different N meningitidis serogroup B strains representative of those that cause serogroup B meningococcal disease in the United States, compared with less than 1% prior to vaccination. (medscape.com)
  • It is uncertain whether individuals with other diseases associated with immunosuppression are at higher risk of acquiring meningococcal disease, as they are for disease caused by other encapsulated bacteria. (cdc.gov)
  • Incomplete protection against invasive meningococcal disease," is common, added Jana Shaw, MD, MPH, a pediatric infectious diseases specialist from Upstate Golisano Children's Hospital in Syracuse, New York. (medscape.com)
  • [ 17 ] Current meningococcal vaccines are indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis . (medscape.com)
  • Despite a declining incidence of invasive meningococcal disease (IMD) in many areas of North America, ongoing challenges to prevention efforts exist, according to an update from the Global Meningococcal Initiative. (medpagetoday.com)
  • Prior influenza infection is a risk factor for invasive meningococcal disease. (nih.gov)
  • Menveo is designed to prevent invasive meningococcal disease caused by Neisseria meningitides serogroups A, C, Y, and W-135. (genengnews.com)
  • In Europe, there were more than 3000 cases of Invasive Meningococcal Disease in 2018, half of them caused by serogroups C, W, and Y," said Thomas Triomphe, head of Sanofi Pasteur, in the press release. (pharmtech.com)
  • Invasive meningococcal disease caused by N. meningitidis is a global public health problem due to its high morbidity and mortality. (scielo.sa.cr)
  • Invasive meningococcal disease can also present as arthritis and pneumonia. (nvic.org)
  • Invasive meningococcal disease may cause permanent injury including brain damage, hearing loss, loss of a limb or death. (nvic.org)
  • On October 29, 2014, a new vaccine against invasive meningococcal disease caused by Neisseria meningitidis serogroup B was licensed by the Food and Drug Administration. (chop.edu)
  • Invasive meningococcal disease is a rare but severe infection in Canada that mostly affects the very young. (canada.ca)
  • Invasive meningococcal disease (IMD) is a serious illness caused by the bacterium Neisseria meningitidis Footnote 1 . (canada.ca)
  • Invasive meningococcal disease caused by some serogroups is vaccine preventable and endemic in Canada, with increased activity occurring periodically in the winter months. (canada.ca)
  • National enhanced case-based surveillance has been conducted in Canada since 1995 through the Public Health Agency of Canada's Enhanced Invasive Meningococcal Disease Surveillance System (eIMDSS). (canada.ca)
  • For instance, Menhibrix is approved to prevent invasive meningococcal disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y. Thus, combination vaccines eliminate the need to administer individual vaccines. (sbwire.com)
  • The FDA has approved the first U.S. vaccine against invasive meningococcal disease caused by Neisseria meningitides serogroup B. Trumenba is approved for use in individuals aged 10 through 25 years. (medscape.com)
  • Problem: Six invasive meningococcal disease cases occurred among Scottish and Swedish nationals associated with the World Scout Jamboree (WSJ), an international mass gathering, held in Japan. (who.int)
  • This outbreak highlighted the risk for international spread of invasive meningococcal disease at international mass gatherings. (who.int)
  • Discussion: Assessing risk, educating participants, enhancing surveillance and sharing timely information among related countries are significant for prevention and response against invasive meningococcal disease outbreaks at mass gatherings. (who.int)
  • Some people get the germs that cause meningococcal disease, but don't get sick - these people are called "carriers. (hhs.gov)
  • The meningococcal vaccines contain only a small piece of the germ, so it can't cause meningococcal disease. (kidshealth.org)
  • Previously, meningococcal vaccines licensed for use in the U.S. only covered four of the five main serogroups of bacteria that cause meningococcal disease: A, C, W and Y. (chop.edu)
  • We're lucky to have effective vaccines against all of the main serogroups that cause meningococcal disease in Aotearoa New Zealand, and current policy is appropriately targeted to the ages when children and young people are most at risk. (sciencemediacentre.co.nz)
  • Meningococcal B continues to be the most common strain of meningococcal disease in Australia. (perthnow.com.au)
  • OSU has seen three confirmed reports of the B strain of meningococcal disease in the past four months. (oregonstate.edu)
  • The meningococcal B strain alleged to be the cause of the meningococcal epidemic is a mild strain of meningococcal disease compared to other sub-types, and based on available data, is responsible for less than 50% of fatalities. (newmediaexplorer.org)
  • Even if you received meningococcal vaccines, you could still get meningococcal disease. (cdc.gov)
  • The meningococcal conjugate vaccine (MenACWY) protects against four types of meningococcal bacteria (types A, C, W, and Y). It is recommended for all kids and teens age 11 and older. (kidshealth.org)
  • Some types of MenACWY are given to younger children (as early as 8 weeks of age) if they have a higher risk of getting meningococcal disease. (kidshealth.org)
  • Kids and teens who are at higher risk for meningococcal disease need the full series of MenACWY vaccines, even if they're younger than 11 years old. (kidshealth.org)
  • The MenACWY vaccine was introduced in the UK in August 2015 to protect teenagers against a harmful strain of meningococcal W (MenW) disease which had been rapidly rising since 2009. (meningitis.org)
  • MenACWY vaccine directly protects vaccinated people from four different strains of meningococcal meningitis and septicaemia (groups A, C, W & Y) and also stops them from carrying the bacteria in the back of the nose and throat. (meningitis.org)
  • In the United States, multiple meningococcal serogroup A, C, W, and Y (MenACWY) conjugate vaccines as well as meningitis serogroup B vaccines are licensed. (medpagetoday.com)
  • In 2020 for meningococcal cases, 85.7 percent of college students (18-24 years) and 69.2 percent of person not attending college (18-24 years) had received at least one dose of MenACWY vaccine. (nvic.org)
  • A person with anatomic or functional asplenia should receive both PCV and meningococcal conjugate vaccines (MenACWY). (immunize.org)
  • The FDOH said you can find meningococcal vaccines, including the MenACWY vaccine, by contacting a health care provider, county health department, or pharmacy. (kbzk.com)
  • In light of the risk, the CDC is recommending gay, bisexual, and other men who have sex with men get a meningococcal vaccine (MenACWY) if they live in Florida or are traveling there. (iflscience.com)
  • Asplenic persons seem also to be at increased risk of developing meningococcal disease and experience particularly severe infections (3). (cdc.gov)
  • Meningococcal (muh-nin-jeh-KOK-el) disease used to cause thousands of serious infections every year. (hhs.gov)
  • Meningococcal disease can cause serious infections of the lining of the brain and spinal cord or the blood. (hhs.gov)
  • But others get meningococcal disease, which can cause serious infections. (hhs.gov)
  • Meningococcal infections in the nasopharynx may cause no symptoms-up to 30 percent of the population may harbour the bacteria between epidemics . (britannica.com)
  • Infections of the lining of the brain and spinal cord in the central nervous system can result in meningococcal meningitis. (britannica.com)
  • Meningococcal disease includes infections of the bloodstream and meningitis. (hopkinsmedicine.org)
  • The vaccine prevents many, but not all meningococcal infections. (hopkinsmedicine.org)
  • The meningococcal vaccines protect against meningococcal disease, which can lead to bacterial meningitis and other serious infections. (kidshealth.org)
  • He said over the past few years about 75 per cent of meningococcal infections in WA had been caused by types C, W and Y. (perthnow.com.au)
  • One of the difficulties with treating meningococcal infections is that they can spread so quickly and cause such an overwhelming infection, that even antibiotics and other supportive treatments can't always stop the infection. (drpaul.com)
  • Please also ensure that you have been vaccinated with the Meningitis C vaccine, offered to all people aged under 25 in the UK, as it protects against one type of meningococcal bacteria. (ucl.ac.uk)
  • While all adolescents are currently recommended to receive the current meningococcal vaccines (either Menactra® or Menveo®), the new serogroup B vaccine, Trumenba®, offers an opportunity to protect against the type of meningococcal infection that was recently diagnosed on the campuses of Princeton University and University of California, Santa Barbara. (chop.edu)
  • The CDC recommends all children receive their first dose of meningococcal serogroup A, C, Y and W-135 conjugate vaccine at age 11-12 and an additional booster dose at age 16. (nvic.org)
  • People with certain chronic conditions appear to be at increased risk of developing meningococcal infection. (cdc.gov)
  • What are the side effects of meningococcal vaccines? (hhs.gov)
  • The Hajj pilgrimage to Saudi Arabia also has been associated with outbreaks of meningococcal disease among returning pilgrims and their contacts, including 4 cases in travelers from the United States during a large Hajj-associated outbreak in 2000. (cdc.gov)
  • One of the worst outbreaks of meningococcal disease among gay and bisexual men in US history has caught the attention of the CDC , which is working hard to get to the bottom of the outbreak. (iflscience.com)
  • The MenB vaccine is recommended for children and adults age 10 years and older who are at increased risk for serogroup B meningococcal disease (doses may vary). (hhs.gov)
  • Meningococcal group B vaccine (MenB) is available to prevent infection by one type of meningitis bacteria that has become common in outbreaks among college students (see CDC: Meningococcal B vaccine information statement ). (msdmanuals.com)
  • For instance - NACI (National Advisory Committee on Immunization), in Dec 2019, did publish scientific recommendation and information on MenB-fHBP (bivalent factor-H binding protein meningococcal serogroup B) vaccine (Trumenba). (articlerich.com)
  • Meningococcal B, or MenB, is an aggressive illness that can lead to death within 24-48 hours of the first symptoms. (pharmaceutical-technology.com)
  • However, because the epidemiology of meningococcal disease can change over time, Mr Cook has told his department to closely monitor the situation. (perthnow.com.au)
  • Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines. (bvsalud.org)
  • Some types of meningococcal vaccines can be given as early as 8 weeks of age. (kidshealth.org)
  • Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. (medlineplus.gov)
  • Getting vaccinated against meningococcal disease is the best way to prevent this serious illness, which can quickly become deadly," José R. Romero, Director of the National Center for Immunization and Respiratory Diseases, said in a statement . (iflscience.com)
  • In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine (MCV4) (Menactra , Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11--55 years. (cdc.gov)
  • Unless use of the meningococcal conjugate vaccine is contraindicated, for pediatric patients, meningococcal conjugate vaccines (ie, Menveo, Menactra, or MenHibrix) are preferred over the meningococcal polysaccharide vaccine (ie, Menomune). (pharmacytimes.com)
  • In 2010, a new meningococcal conjugate vaccine (Menveo) was licensed for use in the United States for 11-55 year-olds and has demonstrated non-inferiority to MCV4 (Menactra). (mn.us)
  • Menactra was licensed for use in the United States in January 2005 for persons aged 11 to 55 years, and was the first meningococcal polysaccharide-protein conjugate vaccine for serogroups A,C,Y, and W-135 (MCV4). (mn.us)
  • Meningococcal septicemia, which is characterized by rapid circulatory collapse and a hemorrhagic rash, is a more severe, but less common, form of meningococcal disease. (medscape.com)
  • Meningococcal septicemia is an infection of the bloodstream that causes bleeding into the skin and organs. (hhs.gov)
  • This bacterium can cause serious and sometimes fatal diseases including meningitis (infection of the brain lining) and meningococcal septicemia (infection of the blood). (gc.ca)
  • Sanofi announced on Nov. 23, 2020 that the European Commission (EC) approved MenQuadfi (meningococcal [groups A, C, Y, W] conjugate vaccine) for immunization against meningococcal meningitis, the inflammation of the brain and spinal cord caused by a viral infection, in patients from the age of 12 months and older. (pharmtech.com)
  • What is the market value of Meningococcal market in 2020? (medgadget.com)
  • According to PersistenceMarketResearch, the global Meningococcal Vaccines Market is slated to witness a CAGR of more than 9% between 2020 and 2030. (articlerich.com)
  • Meningococcal Vaccines Market Research Report covers the present scenario and the growth prospects of the Meningococcal Vaccines Industry for 2016-2020. (sbwire.com)
  • What will the Meningococcal Vaccines market size be in 2020 and what will the growth rate be? (sbwire.com)
  • FDA has approved Novartis' quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2-10 years of age. (genengnews.com)
  • The study compared the safety and immunogenicity of Menveo against each of the four serogroups it is designed to protect against with the safety and efficacy of the other currently U.S.-licensed ACW-135Y meningococcal conjugate vaccine. (genengnews.com)
  • Three vaccines, Menectra (Sanofi Pasteur), Menveo (Novartis/GlaxoSmithKline), and MenQuadfi (Sanofi Pasteur) are conjugate vaccines that target serogroups A, C, Y and W-135 meningococcal bacteria and two vaccines, BEXSERO (Novartis/GlaxoSmithKline) and TRUMENBA (Wyeth/Pfizer) are recombinant vaccines that target serogroup B meningococcal bacteria. (nvic.org)
  • The new formulation called Penbraya is manufactured by Pfizer and combines the components from two existing meningococcal vaccines, Trumenba the group B vaccine and Nimenrix groups A, C, W-135, and Y conjugate vaccine. (medscape.com)
  • Cite this: New Meningococcal Vaccine Wins FDA Approval - Medscape - Oct 23, 2023. (medscape.com)
  • As of November 24, 2023, there have been 46,228 reports of meningococcal vaccine reactions, hospitalizations, injuries and deaths following meningococcal vaccinations made to the federal Vaccine Adverse Events Reporting System (VAERS), including 265 related deaths, 4,922 hospitalizations, and 606 related disabilities. (nvic.org)
  • Pharmac is seeking feedback on the proposal to fund the meningococcal B vaccine from 1 March 2023 for children up to 12 months of age and people aged 13 to 25 years who are entering into or in their first year of close-living situations, such as boarding school hostels. (sciencemediacentre.co.nz)
  • For more information, see the Centers for Disease Control and Prevention's (CDC) Meningococcal vaccine . (msdmanuals.com)
  • A time series analysis of the association of influenza and meningococcal disease using hospitalizations in 9 states from 1989-2009 included in the State Inpatient Databases from the Agency for Healthcare Research and Quality and the proportion of positive influenza tests by subtype reported to the Centers for Disease Control. (nih.gov)
  • The case-fatality rate is approximately 10% for meningococcal meningitis and 20% for meningococcemia, despite therapy with antimicrobial agents, such as penicillin, to which all strains remain highly sensitive. (cdc.gov)
  • These vaccines may also be given to anyone 16 through 23 years old to provide short-term protection against most strains of serogroup B meningococcal disease, based on discussions between the patient and health care provider. (medlineplus.gov)
  • A free vaccine is provided in WA for the meningococcal A, C, W and Y strains but not for the B strain, which costs around $500 for the four doses required. (perthnow.com.au)
  • In a single vaccine, Penbraya has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots. (medscape.com)
  • Individuals most at risk for contracting meningococcal disease are infants, adolescents, young adults and seniors. (nvic.org)
  • In the case of meningococcal meningitis, other symptoms can include stiff neck , vomiting , confusion, and photophobia (increased sensitivity of the eyes to light). (britannica.com)
  • If a person ever develops such a rash, especially in the context of an outbreak of meningococcal infection, medical attention should be sought immediately. (drpaul.com)
  • State health officials want you to know what to watch for while they monitor an outbreak of meningococcal disease in Florida. (kbzk.com)
  • Increasing the inclusion of meningococcal vaccines into the NIPs [national immunization programs] of North American countries beyond the US, Canada, and Cuba, is an important milestone that should remain a focus of public health authorities. (medpagetoday.com)
  • Quantifying the fraction of meningococcal disease attributable to influenza could improve understanding of viral-bacterial interaction and indicate additional health benefits to influenza immunization. (nih.gov)
  • Unvaccinated travelers visiting meningitis belt countries and having prolonged contact with local populations during an epidemic are at greatest risk for meningococcal disease. (cdc.gov)
  • No major epidemic of meningococcal disease has occurred in the United States since 1946, although localized community outbreaks have been reported. (cdc.gov)
  • HARRISONBURG, Va. (WHSV) - Since June 2022, there have been 27 confirmed cases of Meningococcal Disease across Virginia and 5 deaths, according to the Virginia Department of Health. (nbc29.com)
  • Edwin J. Asturias, MD, with the University of Colorado, in Aurora, Colorado, and colleagues provided an update from the Global Meningococcal Initiative in the December 2022 issue of Journal of Infection . (medpagetoday.com)
  • Up to this point, health officials say the number of cases identified in 2022 surpasses the 5-year average of meningococcal disease cases in Florida. (kbzk.com)
  • The Florida Department of Health (FDOH) said, so far in 2022, they've identified 21 meningococcal disease cases in Florida residents, and half of those have been in people who identify as men who have sex with men. (kbzk.com)
  • As per the report published by Allied Market Research, the global Meningococcal Vaccine Industry garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. (medgadget.com)
  • In October 2014, the FDA approved the first meningococcal vaccine for serogroup B (Trumenba) under the breakthrough therapy designation and accelerated approval regulatory pathways. (medscape.com)
  • The threat of another major meningococcal disease outbreak has been concerning for some time but there are effective vaccines available. (sciencemediacentre.co.nz)
  • Most of the recent meningococcal cases in the NT have been the severe W strain of the disease. (abc.net.au)
  • 2 years, meningococcal disease can have nonspecific symptoms. (cdc.gov)
  • Meningococcal disease is scary because it can progress from initial symptoms to death in as little as 24 hours. (chop.edu)
  • Today marks an important step forward in the prevention of meningococcal disease in the US," Annaliesa Anderson, PhD, head of vaccine research and development at Pfizer, said in a news release. (medscape.com)
  • Deterrence and prevention of meningococcal meningitis can be achieved by either immunoprophylaxis or chemoprophylaxis. (medscape.com)
  • This is the first pentavalent vaccine for meningococcal disease and is approved for use in people aged 10-25. (medscape.com)
  • The FDA's decision is based on the positive results from phase 2 and phase 3 trials, including a randomized, active-controlled and observer-blinded phase 3 trial assessing the safety, tolerability, and immunogenicity of the pentavalent vaccine candidate compared with currently licensed meningococcal vaccines. (medscape.com)
  • All formulations of the meningococcal vaccine are conjugated polysaccharide vaccines, with the exception of Menomune, which is a polysaccharide vaccine. (pharmacytimes.com)
  • Meningococcal disease is hyperendemic in this region, and periodic epidemics during the dry season (December-June) reach an incidence of up to 1,000 cases per 100,000 population. (cdc.gov)
  • Meningococcal disease generally occurs 1-10 days after exposure and presents as meningitis in ≈50% of cases in the United States. (cdc.gov)
  • Thanks to vaccines, there are fewer cases of meningococcal disease in the United States than ever before. (hhs.gov)
  • There are very few other bacteria that can kill someone within hours but this is one of them and cases of Meningococcal disease are increasing. (science.org.au)
  • For example, in 2014/15 MenW accounted for 24% of cases of meningococcal disease in England compared to only 1-2% in 2008/9. (meningitis.org)
  • There were 57 cases of meningococcal B infection in WA in 2000 and 12 in 2017, a more than four-fold reduction in the annual incidence," he said. (perthnow.com.au)
  • There are many different subtypes of the bacteria, but five of the subtypes (A, B, C, Y and W135) are responsible for the majority of meningococcal cases. (gc.ca)
  • Detailed analysis of Ministry of Health data reveals that notified meningococcal disease cases are at a 10 year low, and deaths are at a 13 year low," says risk & policy analyst Ron Law. (newmediaexplorer.org)
  • The ESR itself estimates that between 10% and 26% of cases notified have been misdiagnosed and are not meningococcal disease. (newmediaexplorer.org)
  • Analysis of available data shows that nationally, less than 50% of the total notified cases have been confirmed as being caused by the MeNZB type meningococcal bacteria. (newmediaexplorer.org)
  • 4 Despite the fact that serogroup B meningitis affects children disproportionately, currently, no vaccine is available in the United States that protects patients against serogroup B, which may be why the meningococcal vaccine is only recommended in selected groups of very young children. (pharmacytimes.com)
  • The incidence of endemic meningococcal disease peaks in the late winter to early spring. (cdc.gov)
  • Most infants should not receive the meningococcal vaccine. (pharmacytimes.com)
  • Pharmac is proposing to widen access to the meningococcal B vaccine, Bexsero, to include infants and some young adults. (sciencemediacentre.co.nz)
  • Region wise, North America was the major shareholder and accounted for 49.84% of the meningococcal vaccine market share in 2018. (medgadget.com)
  • Approximately 30% of people with meningococcal disease present with meningococcal sepsis, known as meningococcemia. (cdc.gov)